All News

To view HEALTH PROFESSIONAL NEWS - click here
To view COMMUNITY NEWS - click here

March 2021: Research Update

First sites for INTEGRATE IIb to open soon The INTEGRATE II trial has transitioned to a INTEGRATE IIb after the study was updated to incorporate a promising new treatment. The purpose of INTEGRATE II was to determine whether regorafenib improved overall survival for people with advanced gastro-oesophageal cancer. INTEGRATE IIb... Read More